BNC Korea Co., Ltd. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 5,140.00
-10.00 (-0.19%)
Aug 14, 2025, 2:40 PM KST
BNC Korea Market Cap
BNC Korea has a market cap or net worth of 346.08 billion as of August 14, 2025. Its market cap has decreased by -12.75% in one year.
Market Cap
346.08B
Enterprise Value
273.35B
Revenue
97.43B
Ranking
n/a
PE Ratio
21.59
Stock Price
5,140.00
Market Cap Chart
Since November 18, 2019, BNC Korea's market cap has increased from 15.37B to 346.08B, an increase of 2,151.14%. That is a compound annual growth rate of 71.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 346.08B | 25.51% |
| Dec 30, 2024 | 275.74B | 12.30% |
| Dec 28, 2023 | 245.55B | -20.03% |
| Dec 29, 2022 | 307.06B | -78.68% |
| Dec 30, 2021 | 1,440.31B | 557.65% |
| Dec 30, 2020 | 219.01B | 174.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 38.80T |
| ALTEOGEN | 24.00T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |